BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16385573)

  • 21. Ursodeoxycholic acid and in vitro vasoactivity of hydrophobic bile acids.
    Bomzon A; Ljubuncic P
    Dig Dis Sci; 2001 Sep; 46(9):2017-24. PubMed ID: 11575458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of colonic xenobiotic metabolizing enzymes by feeding bile acids: comparative effects of cholic, deoxycholic, lithocholic and ursodeoxycholic acids.
    Baijal PK; Fitzpatrick DW; Bird RP
    Food Chem Toxicol; 1998 Jul; 36(7):601-7. PubMed ID: 9687967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opposing effects of bile acids deoxycholic acid and ursodeoxycholic acid on signal transduction pathways in oesophageal cancer cells.
    Abdel-Latif MM; Inoue H; Reynolds JV
    Eur J Cancer Prev; 2016 Sep; 25(5):368-79. PubMed ID: 26378497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of dietary folate on ulcerative colitis-associated colorectal carcinogenesis in the interleukin 2- and beta(2)-microglobulin-deficient mice.
    Carrier J; Medline A; Sohn KJ; Choi M; Martin R; Hwang SW; Kim YI
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1262-7. PubMed ID: 14652292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemoprevention of N-methylnitrosourea-induced colon carcinogenesis by ursodeoxycholic acid-5-aminosalicylic acid conjugate in F344 rats.
    Narisawa T; Fukaura Y; Takeba N; Nakai K
    Jpn J Cancer Res; 2002 Feb; 93(2):143-50. PubMed ID: 11856477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of ursodeoxycholic acid and/or low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia.
    Fan JG; Zhong L; Tia LY; Xu ZJ; Li MS; Wang GL
    World J Gastroenterol; 2005 Apr; 11(15):2346-50. PubMed ID: 15818751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia.
    Lindström L; Boberg KM; Wikman O; Friis-Liby I; Hultcrantz R; Prytz H; Sandberg-Gertzén H; Sangfelt P; Rydning A; Folvik G; Gangsøy-Kristiansen M; Danielsson A; Bergquist A
    Aliment Pharmacol Ther; 2012 Feb; 35(4):451-7. PubMed ID: 22221173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production.
    Ishizaki K; Iwaki T; Kinoshita S; Koyama M; Fukunari A; Tanaka H; Tsurufuji M; Sakata K; Maeda Y; Imada T; Chiba K
    Eur J Pharmacol; 2008 Jan; 578(1):57-64. PubMed ID: 17888421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ursodeoxycholic acid can suppress deoxycholic acid-induced apoptosis by stimulating Akt/PKB-dependent survival signaling.
    Im E; Akare S; Powell A; Martinez JD
    Nutr Cancer; 2005; 51(1):110-6. PubMed ID: 15749637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
    Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
    J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-3 polyunsaturated fatty acid attenuates cholesterol gallstones by suppressing mucin production with a high cholesterol diet in mice.
    Kim JK; Cho SM; Kang SH; Kim E; Yi H; Yun ES; Lee DG; Cho HJ; Paik YH; Choi YK; Haam SJ; Shin HC; Lee DK
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1745-51. PubMed ID: 22849613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of ursodeoxycholic acid on serum and biliary noncholesterol sterols in patients with gallstones.
    Miettinen TE; Tarpila S; Gylling H
    Hepatology; 1997 Mar; 25(3):514-8. PubMed ID: 9049189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ursodeoxycholic acid protects against intestinal barrier breakdown by promoting enterocyte migration via EGFR- and COX-2-dependent mechanisms.
    Golden JM; Escobar OH; Nguyen MVL; Mallicote MU; Kavarian P; Frey MR; Gayer CP
    Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G259-G271. PubMed ID: 29672156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.
    Sjöqvist U; Tribukait B; Ost A; Einarsson C; Oxelmark L; Löfberg R
    Anticancer Res; 2004; 24(5B):3121-7. PubMed ID: 15510599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Disturbances in biliary secretion during tissue hypoxia and attempts at their corrections].
    Hovorukha TM; Nazarenko AI; Zhalilo LI; Fil' HB; Baban VM; Seredenko MM
    Fiziol Zh (1994); 2002; 48(1):35-40. PubMed ID: 11928630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The bile acids, deoxycholic acid and ursodeoxycholic acid, regulate colonic epithelial wound healing.
    Mroz MS; Lajczak NK; Goggins BJ; Keely S; Keely SJ
    Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G378-G387. PubMed ID: 29351391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ursodeoxycholic acid (UDCA) can inhibit deoxycholic acid (DCA)-induced apoptosis via modulation of EGFR/Raf-1/ERK signaling in human colon cancer cells.
    Im E; Martinez JD
    J Nutr; 2004 Feb; 134(2):483-6. PubMed ID: 14747693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The correlation between NF-κB inhibition and disease activity by coadministration of silibinin and ursodeoxycholic acid in experimental colitis.
    Esmaily H; Vaziri-Bami A; Miroliaee AE; Baeeri M; Abdollahi M
    Fundam Clin Pharmacol; 2011 Dec; 25(6):723-33. PubMed ID: 21077947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different effects of bile acids, ursodeoxycholic acid and deoxycholic acid, on cell growth and cell death in human colonic adenocarcinoma cells.
    Shiraki K; Ito T; Sugimoto K; Fuke H; Inoue T; Miyashita K; Yamanaka T; Suzuki M; Nabeshima K; Nakano T; Takase K
    Int J Mol Med; 2005 Oct; 16(4):729-33. PubMed ID: 16142412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice.
    Tsuchida T; Shiraishi M; Ohta T; Sakai K; Ishii S
    Metabolism; 2012 Jul; 61(7):944-53. PubMed ID: 22154323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.